Quantcast

Latest Sanofi US Stories

2014-06-14 12:21:03

-- Real World Outcome Study of Patients with Type 2 Diabetes Presented at American Diabetes Association 74th Scientific Sessions -- BRIDGEWATER, N.J., June 14, 2014 /PRNewswire/ -- Sanofi US announced today results from a real world outcome study of type 2 diabetes (T2D) patients that show switching from Lantus® (insulin glargine [rDNA origin] injection) to insulin detemir demonstrated higher average blood sugar levels (A1C) and lower A1C reduction over a span of 12 months compared...

2014-06-14 12:20:58

During the 1-year program, patients showed statistically significant reductions in blood glucose levels, increased belief in their ability to self-manage their diabetes and improved perceptions of support, while the community showed statistically significant increases in diabetes awareness SAN FRANCISCO, June 14, 2014 /PRNewswire/ -- The American Academy of Family Physicians Foundation announced today that the Cities for Life program, supported by Sanofi US, helped decrease blood glucose...

2014-05-13 08:27:48

- What's Your AQ? Answers Common Anaphylaxis Questions During National Asthma and Allergy Awareness Month - BRIDGEWATER, N.J., May 13, 2014 /PRNewswire/ -- Professional football icon Jerome Bettis, the Asthma and Allergy Foundation of America (AAFA) and Sanofi US, the makers of Auvi-Q(®) (epinephrine injection, USP), are asking What's Your AQ? in an effort to help improve America's understanding of severe, life-threatening allergic reactions (anaphylaxis) and to help clear up some...

2014-05-12 12:30:47

$100,000 prize and access to additional expertise awarded to support "big data" genetic analysis to provide new clues to the higher incidence of ALS in veterans BRIDGEWATER, N.J., May 12, 2014 /PRNewswire/ -- Sanofi US announced the winner of its second Innovation Challenge: Collaborate Innovate. The winner, Veterans Advancing ALS/MND, is a partnership that comprises Innovative Solutions Consortium and Johns Hopkins University. In the spirit of collaboration, Sanofi's Partners in Patient...

2014-05-01 16:33:47

Direct Relief to distribute product across America to nonprofit health centers, clinics, and allergy camps SANTA BARBARA, Calif., May 1, 2014 /PRNewswire-USNewswire/ -- The Sanofi Foundation for North America has donated more than 90,000 Auvi-Q(®) (epinephrine injection, USP) epinephrine auto-injectors to medical aid organization Direct Relief for distribution to nonprofit health centers, clinics, and allergy camps across the U.S. that care for people at risk of life-threatening...

2014-02-04 12:28:20

First and only medicine in its class approved for over-the-counter use that provides 24 hour relief of the full range of nasal allergy symptoms including nasal congestion BRIDGEWATER, N.J., Feb. 4, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and its U.S. consumer healthcare division Chattem announced today that Nasacort(®) Allergy 24HR Nasal Spray is now available over-the-counter (OTC) in the U.S. to relieve the full range of seasonal and year-round nasal allergy...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related